Ophthalmic Pharmacology Practice Questions

Q: Tachyphylaxis is an adverse effect of which of the following medications?

Dipevifrine. **Explanation:** **Tachyphylaxis** refers to a rapid decrease in the response to a drug after repeated doses (acute tolerance). In ophthalmology, this phenomenon is most characteristically associated with **Adrenergic agonists**, specifically **Dipivefrine** and Epinephrine. **Why Dipivefrine is correct:** Dipivefrine is a prodrug of Epinephrine. It acts on $\alpha$ and $\beta$ receptors to increase uveoscleral outflow and decrease aqueous production. With chronic use, the adrenergic receptors undergo "downregulation" or desensitization, leading to a rapid loss of the intraocular pressure (IOP) lowering effect. Additionally, Dipivefrine is notorious for causing **Adrenochrome deposits** in the conjunctiva and nasolacrimal duct. **Why other options are incorrect:** * **Betaxolol:** A cardioselective $\beta_1$-blocker. While "long-term drift" (slow loss of efficacy over months/years) can occur with beta-blockers, they do not typically exhibit the rapid tachyphylaxis seen with adrenergics. * **Latanoprost:** A Prostaglandin analogue (PGF2$\alpha$). These are the first-line drugs for glaucoma and are preferred because they maintain stable efficacy over long periods without significant tachyphylaxis. * **Dorzolamide:** A topical Carbonic Anhydrase Inhibitor (CAI). Its effect remains relatively constant as long as the enzyme inhibition is maintained. **High-Yield Clinical Pearls for NEET-PG:** * **Dipivefrine** is more lipophilic than Epinephrine, allowing better corneal penetration and fewer systemic side effects. * **Apraclonidine** (an $\alpha_2$ agonist) also shows significant tachyphylaxis, which is why it is used for short-term prophylaxis (e.g., post-laser) rather than chronic glaucoma management. * **Brimonidine** (selective $\alpha_2$ agonist) is less likely to cause tachyphylaxis compared to Apraclonidine but is highly associated with **follicular conjunctivitis**.

Q: What is the treatment of choice for acute anterior uveitis?

Local steroids. **Explanation:** **Acute Anterior Uveitis (AAU)** is characterized by a breakdown of the blood-aqueous barrier, leading to the presence of cells and flare in the anterior chamber. The primary goal of treatment is to suppress inflammation, prevent the formation of posterior synechiae, and reduce the risk of secondary complications like glaucoma or cataracts. 1. **Why Local Steroids are the Treatment of Choice:** Topical (local) corticosteroids are the mainstay of therapy because they achieve high therapeutic concentrations directly in the anterior segment of the eye. They inhibit the arachidonic acid pathway, reducing both prostaglandins and leukotrienes. Frequent instillation (e.g., Prednisolone acetate 1% every 1–2 hours) is highly effective in controlling acute inflammation without the systemic side effects associated with oral steroids. 2. **Why Other Options are Incorrect:** * **Systemic Steroids:** These are reserved for posterior uveitis, panuveitis, or severe bilateral cases resistant to topical therapy. For simple AAU, the systemic side-effect profile outweighs the benefits. * **Local/Systemic NSAIDs:** While NSAIDs inhibit cyclooxygenase, they are significantly less potent than steroids in controlling the intense inflammatory cascade of acute uveitis. They may be used as adjuncts but are never the primary treatment of choice. **High-Yield Clinical Pearls for NEET-PG:** * **The "Mydriatic-Cycloplegic" Duo:** Always use topical steroids in conjunction with cycloplegics (e.g., Atropine or Homatropine). Cycloplegics provide pain relief by relieving ciliary spasm and prevent/break posterior synechiae. * **Drug of Choice:** **Prednisolone acetate (1%)** is the most effective topical steroid due to its superior intraocular penetration. * **Steroid-Induced Glaucoma:** Always monitor intraocular pressure (IOP) during treatment, as steroids can decrease aqueous outflow.

Q: Which drug is contraindicated in dendritic keratitis?

Dexamethasone. **Explanation:** **Dendritic keratitis** is the hallmark clinical presentation of **Herpes Simplex Virus (HSV)** epithelial keratitis. The correct answer is **Dexamethasone** (a potent topical steroid). **Why Dexamethasone is Contraindicated:** Topical corticosteroids are strictly contraindicated in active epithelial viral infections. Steroids suppress the local immune response and enhance viral replication. In dendritic keratitis, steroids can cause the linear dendrite to enlarge into a large, geographic ulcer (**Geographic Keratitis**). Furthermore, they increase the risk of corneal melting and perforation by inhibiting collagen synthesis. **Analysis of Other Options:** * **5% Idoxuridine:** This is a topical antiviral agent. While newer drugs like Ganciclovir or Acyclovir are now preferred due to lower toxicity, Idoxuridine was historically used to treat HSV keratitis. * **Cycloplegics (e.g., Atropine/Homatropine):** These are indicated to relieve ciliary spasms and prevent the formation of posterior synechiae caused by secondary iridocyclitis associated with the viral infection. * **Topical Antibiotics:** These are often prescribed as prophylaxis to prevent secondary bacterial superinfection of the epithelial defect. **High-Yield Clinical Pearls for NEET-PG:** * **Staining:** Dendritic ulcers show **central staining** with Fluorescein (denuded epithelium) and **terminal bulbs** that stain with Rose Bengal (devitalized virus-laden cells at the margin). * **Steroid Exception:** Steroids are *only* used in HSV when the infection is **Stromal (Disciform Keratitis)**, but even then, they must be covered by a prophylactic antiviral. * **Sensation:** Always check for **reduced corneal sensations** in suspected HSV keratitis.

Q: What is the drug of choice for acute iridocyclitis?

Steroids. **Explanation:** **Acute Iridocyclitis** (Anterior Uveitis) is characterized by inflammation of the iris and ciliary body. The primary goals of management are to control inflammation, prevent the formation of synechiae, and reduce pain. **1. Why Steroids are the Correct Answer:** Steroids are the **mainstay of treatment** because they directly address the underlying pathophysiology: inflammation. They act by inhibiting the arachidonic acid pathway, thereby reducing capillary permeability and suppressing the exudation of inflammatory cells and proteins. In acute cases, topical steroids (e.g., Prednisolone acetate 1%) are administered frequently to prevent permanent ocular damage and vision loss. **2. Analysis of Incorrect Options:** * **B. Acetazolamide:** This is a carbonic anhydrase inhibitor used to lower Intraocular Pressure (IOP). While it may be used as an adjunct if secondary glaucoma develops, it does not treat the primary inflammatory process. * **C. Atropine:** This is a potent cycloplegic. While it is a crucial component of treatment (to provide comfort by relieving ciliary spasm and to prevent posterior synechiae), it is considered **supportive therapy**. Steroids remain the definitive "drug of choice" to halt the disease process. * **D. Antibiotics:** Most cases of acute iridocyclitis are sterile/autoimmune in nature. Antibiotics have no role unless a specific bacterial infection is identified. **Clinical Pearls for NEET-PG:** * **The "Mydriatic-Cycloplegic" of choice:** Atropine 1% ointment or drops. * **Steroid Side Effects:** Long-term topical steroid use can lead to **steroid-induced glaucoma** and **posterior subcapsular cataracts**. * **Signs of Iridocyclitis:** Ciliary congestion, aqueous flare/cells, Keratic Precipitates (KPs), and miosis. * **Important Association:** HLA-B27 is the most common systemic association with acute anterior uveitis.

Q: Which of the following agents acts as a mydriatic?

Tropicamide. **Explanation:** The correct answer is **D. All of the above**. *Note: While the prompt indicates Tropicamide as the marked correct answer, pharmacologically, all three options belong to the class of **Antimuscarinic (Anticholinergic) agents** which act as both mydriatics (dilating the pupil) and cycloplegics (paralyzing the ciliary muscle).* **1. Why all options are correct:** Mydriatics are drugs that cause dilation of the pupil by blocking the M3 receptors on the sphincter pupillae muscle. * **Tropicamide:** The shortest-acting mydriatic (duration 4–6 hours). It is the drug of choice for diagnostic ophthalmoscopy due to its rapid onset and brief recovery period. * **Homatropine:** An intermediate-acting agent (duration 2–3 days). It is frequently used in the treatment of anterior uveitis to prevent the formation of synechiae. * **Atropine:** The most potent and longest-acting agent (duration 7–10 days). It is the drug of choice for refraction in children under 7 years (due to strong accommodation) and for treating severe uveitis. **2. Clinical Pearls for NEET-PG:** * **Drug of choice for Fundus Examination:** Tropicamide (Fastest action). * **Drug of choice for Refraction in Children:** Atropine (Ointment is preferred over drops to prevent systemic toxicity via the nasolacrimal duct). * **Drug of choice for Refraction in Adults:** Homatropine or Cyclopentolate. * **Side Effects:** All these agents can precipitate **Acute Angle Closure Glaucoma** in predisposed individuals with narrow anterior chamber angles. * **Phenylephrine:** An alternative mydriatic that acts as an alpha-1 agonist; it causes mydriasis *without* cycloplegia [1].

Q: A 26-year-old male being treated for glaucoma complains of burning sensation in the eye, blurred vision, and dry eyes after receiving drug A. Examination confirmed corneal hypoesthesia. He has no complaints of headache, nausea, vomiting, or sweating. What drug was he likely treated with?

Timolol. The correct answer is **Timolol**, a non-selective beta-blocker commonly used as a first-line treatment for glaucoma. ### **Explanation of the Correct Answer** Timolol reduces intraocular pressure (IOP) by decreasing aqueous humor production from the ciliary body. A classic, high-yield side effect of topical beta-blockers is **corneal hypoesthesia** (reduced corneal sensitivity). This occurs due to a "membrane-stabilizing" or local anesthetic-like effect on the corneal nerves. Patients often present with symptoms of **dry eyes** and **blurred vision** because the reduced sensitivity leads to a decreased blink rate and tear film instability. The absence of headache, nausea, vomiting, or sweating helps rule out cholinergic side effects (Pilocarpine) or systemic adrenergic stimulation. ### **Why Other Options are Incorrect** * **Pilocarpine:** As a miotic (parasympathomimetic), it typically causes **miosis** (pupillary constriction), **accommodative spasm** (leading to brow ache/headache), and systemic side effects like sweating or nausea. It does not cause corneal anesthesia. * **Dipivefrin:** This is a prodrug of epinephrine. It typically causes **mydriasis** (pupillary dilation) and may lead to conjunctival hyperemia (redness) or systemic sympathetic effects like palpitations and hypertension, rather than corneal hypoesthesia. ### **NEET-PG High-Yield Pearls** * **Corneal Hypoesthesia:** Most commonly associated with **Timolol** and **Betaxolol** in ophthalmic practice. * **Contraindications for Timolol:** Always screen for **Bronchial Asthma** and **Heart Block**, as systemic absorption through the nasolacrimal duct can trigger bronchospasm or bradycardia. * **Punctal Occlusion:** Advise patients to apply pressure over the lacrimal sac for 1–2 minutes after instillation to minimize systemic absorption of beta-blockers.

Q: Which short-acting mydriatic is used in fundoscopy?

Tropicamide. **Explanation:** The correct answer is **Tropicamide**. In clinical practice, the choice of a mydriatic (pupil dilator) depends on the desired duration of action and the clinical objective. For **fundoscopy**, the goal is to achieve rapid dilation with a quick recovery time so the patient can resume normal activities (like driving) shortly after the exam. **Why Tropicamide is correct:** Tropicamide is a synthetic antimuscarinic drug with the **fastest onset (15–30 minutes)** and the **shortest duration of action (4–6 hours)**. It primarily causes mydriasis with minimal cycloplegia (paralysis of accommodation), making it the gold standard for routine diagnostic retinal examinations. **Why the other options are incorrect:** * **Atropine (A):** This is the most potent and longest-acting anticholinergic. Its effects can last for **7–10 days**, making it unsuitable for routine fundoscopy. It is primarily used for refraction in children under 5 and for treating uveitis. * **Homatropine (B):** A semi-synthetic derivative of atropine with a duration of **2–3 days**. It is too long-acting for diagnostic use and is typically used in the management of anterior uveitis to prevent synechiae. * **Cyclopentolate (C):** While faster than homatropine, it still lasts for **24 hours**. It has potent cycloplegic properties and is the drug of choice for **cycloplegic refraction** in children (ages 5–15). **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Duration (Longest to Shortest):** **A**ll **H**umans **C**an **T**rust (Atropine > Homatropine > Cyclopentolate > Tropicamide). * **Phenylephrine:** Often used in combination with Tropicamide to enhance dilation via alpha-1 adrenergic stimulation (acting on the dilator pupillae), without affecting accommodation. * **Contraindication:** Always check the anterior chamber angle before instilling mydriatics to avoid precipitating **Acute Angle Closure Glaucoma**.

Q: What is the drug of choice for acute anterior uveitis?

Atropine. **Explanation:** In the management of **acute anterior uveitis**, the primary goals are to provide symptomatic relief, prevent the formation of posterior synechiae, and reduce inflammation. **Why Atropine is the Drug of Choice (DOC):** While steroids treat the underlying inflammation, **Atropine (1% ointment or drops)** is traditionally considered the "drug of choice" or the most essential initial medication because it addresses the immediate complications of the disease. It acts as a potent **cycloplegic and mydriatic**, serving three critical functions: 1. **Ciliary Muscle Rest:** It paralyzes the ciliary muscle, relieving the painful ciliary spasms (photophobia and deep ache). 2. **Prevents Posterior Synechiae:** By keeping the pupil dilated, it prevents the iris from adhering to the anterior lens capsule. 3. **Breaks Existing Synechiae:** It helps break freshly formed adhesions. **Analysis of Other Options:** * **Topical Steroids (Option A):** These are the mainstay for controlling inflammation (reducing cells and flare), but they are usually considered the second most important step after initiating cycloplegia to prevent permanent structural damage. * **Systemic Steroids (Option C):** These are reserved for severe, bilateral, or recalcitrant cases of uveitis that do not respond to topical therapy. * **NSAIDs (Option D):** These have a limited role and are generally insufficient to manage the intense intraocular inflammation of acute uveitis. **High-Yield Clinical Pearls for NEET-PG:** * **Mydriatic of choice:** Atropine (long-acting) is preferred in acute stages; Homatropine or Cyclopentolate may be used in milder cases. * **The "D"s of Uveitis Management:** **D**ilate the pupil, **D**rop the inflammation (steroids), and **D**etect the cause. * **Complication:** If posterior synechiae form 360°, it leads to *seclusio pupillae*, causing *iris bombe* and secondary angle-closure glaucoma.

Q: Ganciclovir is used intravitreally for the treatment of?

Cytomegalovirus (CMV) retinitis. **Explanation:** **Correct Answer: D. Cytomegalovirus (CMV) retinitis** **Mechanism and Clinical Use:** Ganciclovir is a potent antiviral agent that acts as a nucleoside analogue, specifically inhibiting viral DNA polymerase. While it has activity against several herpesviruses, its primary clinical indication in ophthalmology is the treatment of **Cytomegalovirus (CMV) retinitis**, a sight-threatening opportunistic infection typically seen in immunocompromised patients (e.g., those with AIDS or post-organ transplant). Intravitreal administration (via injection or the Ganciclovir implant) is preferred because it achieves high therapeutic concentrations directly at the retina, bypassing the systemic side effects (like bone marrow suppression) associated with intravenous delivery. **Analysis of Incorrect Options:** * **A & B (Influenza and Rhinovirus):** These are RNA viruses. Ganciclovir is specifically an anti-DNA virus medication and has no efficacy against respiratory viruses like Influenza or Rhinovirus. * **C (Herpes Zoster Virus):** While Ganciclovir has some activity against HZV, it is not the drug of choice. HZV-related conditions (like Herpes Zoster Ophthalmicus) are primarily treated with **Acyclovir, Valacyclovir, or Famciclovir**. **High-Yield NEET-PG Pearls:** * **DOC for CMV Retinitis:** Valganciclovir (oral) or Ganciclovir (IV/Intravitreal). Foscarnet and Cidofovir are second-line agents. * **Classic Appearance:** CMV retinitis presents as "Pizza-pie" or "Cottage cheese and ketchup" fundus (hemorrhage with yellow-white exudates). * **Side Effect:** The most serious systemic side effect of Ganciclovir is **neutropenia/bone marrow suppression**. * **Ganciclovir Implant:** Known as *Vitrasert*, it provides sustained release but is now less commonly used due to the efficacy of highly active antiretroviral therapy (HAART).

Question 1

Tachyphylaxis is an adverse effect of which of the following medications?

Accepted Answer

Dipevifrine

Answer

Betaxalol

Answer

Latanoprost

Answer

Dorzolamide

Question 2

What is the treatment of choice for acute anterior uveitis?

Accepted Answer

Local steroids

Answer

Systemic steroids

Answer

Local NSAIDs

Answer

Systemic NSAIDs

Question 3

Which drug is contraindicated in dendritic keratitis?

Accepted Answer

Dexamethasone

Answer

5% idoxuridine

Answer

Cycloplegics

Answer

Topical antibiotics

Question 4

What is the drug of choice for acute iridocyclitis?

Accepted Answer

Steroids

Answer

Acetazolamide

Answer

Atropine

Answer

Antibodies

Question 5

Which of the following agents acts as a mydriatic?

Accepted Answer

Tropicamide

Answer

Atropine

Answer

Homatropine

Answer

All of the above

Question 6

A 26-year-old male being treated for glaucoma complains of burning sensation in the eye, blurred vision, and dry eyes after receiving drug A. Examination confirmed corneal hypoesthesia. He has no complaints of headache, nausea, vomiting, or sweating. What drug was he likely treated with?

Accepted Answer

Timolol

Answer

Pilocarpine

Answer

Dipivefrin

Answer

Dipivefrin

Question 7

Which short-acting mydriatic is used in fundoscopy?

Accepted Answer

Tropicamide

Answer

Atropine

Answer

Homatropine

Answer

Cyclopentolate

Question 8

What is the drug of choice for acute anterior uveitis?

Accepted Answer

Atropine

Answer

Topical steroids

Answer

Systemic steroids

Answer

NSAIDs

Question 9

Intraocular penetration of topically-instilled drugs is mainly determined by the corneal:

Accepted Answer

Epithelium

Answer

Endothelium

Answer

Stroma

Answer

Bowman's and Descemet's membrane

Question 10

Ganciclovir is used intravitreally for the treatment of?

Accepted Answer

Cytomegalovirus (CMV) retinitis

Answer

Influenza

Answer

Rhinovirus

Answer

Herpes Zoster Virus (HZV)

Ophthalmic Pharmacology — MCQs

Ophthalmic Pharmacology — MCQs

On this page

Practice by Chapter

Want unlimited practice?